A carregar...

Emerging immunotherapies for glioblastoma

Immunotherapy for brain cancer has evolved dramatically over the past decade, owed in part to our improved understanding of how the immune system interacts with tumors residing within the central nervous system (CNS). Glioblastoma (GBM), the most common brain tumor in adults, carries a poor prognosi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Expert Opin Emerg Drugs
Main Authors: Desai, Rupen, Suryadevara, Carter M., Batich, Kristen A., Harrison Farber, S., Sanchez-Perez, Luis, Sampson, John H.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4915370/
https://ncbi.nlm.nih.gov/pubmed/27223671
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14728214.2016.1186643
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!